Forest Counting On Memantine, Benicar, To Bolster Growth Post-Celexa
Executive Summary
Forest expects its Alzheimer's drug memantine to be approved for moderate to severe disease in the spring of 2004, Chief Operating Officer Kenneth Goodman said during a fiscal 2003 fourth quarter earnings call April 22
You may also be interested in...
Lexapro Switch Takes New Twist: Forest Launching Celexa Generic In 2005
Forest plans to launch a generic version of its antidepressant Celexa in early 2005
Forest Namenda Clears FDA; Alzheimer Drug Shipments To Begin In December
Forest is planning a slow roll-out of Namenda (memantine) after a faster-than-expected approval of the Alzheimer's agent
Lexapro Switch Takes New Twist: Forest Launching Celexa Generic In 2005
Forest plans to launch a generic version of its antidepressant Celexa in early 2005
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: